Supply Top Quality Raw Powder Ceftiofur Hydrochloride CAS: 103980-44-5 with 99% Purity

• Varieties: Antibiotic
• Type: The Third Class
• Pharmacodynamic Influential Factors: Animal Species
• Storage Method: Keep in a Cool, Dry, Dark Location
• MW: 560.01
• Character: off-White Powder
• Sterility or Not: Sterile
• Shelf Life: 2 Years
• Quality: Industrial
• CAS.No: 103980-44-5
• Transport Package: 5kg/Tin; 10kg/Tin; 25kg/Drum
• Specification: USP; EP; CVP; IN-HOUSE
• Trademark: Jinan Andechem
• Origin: China
• HS Code: 2941905990
• Production Capacity: 3000kg/Month

Product Description

Product Name	Ceftiofur Hydrochlorid
CAS No.	103980-44-5
MF	C19H17N5O7S3
Appearance	White Powder
Packing	5kg/tin, 2tins/carton; 10KG/tin, 2tins/carton, 25kg/drum
Specification	GMP, ISO 9001, USP, BP
Shelf life	2 Years

Description:
Ceftiofur Hydrochloride is the hydrochloride salt form of ceftiofur, a semisynthetic, beta-lactamase-stable, broad-spectrum, third-generation cephalosporin with antibacterial activity. Ceftiofur binds to and inactivates penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. PBPs are enzymes involved in the terminal stages of assembling the bacterial cell wall and in reshaping the cell wall during growth and division. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis.

Uses:
Ceftiofur hydrochloride (ceftiofur) has been approved for treatment against respiratory diseases in many animals.1,3,8-10 The recommended dosage regimen of ceftiofur for the treatment of swine respiratory disease is 3-5 mg/kg body weight (BW) administered intramuscularly once daily for 3-5 consecutive days.

Veterinary Drugs and Treatments:
In swine, ceftiofur HCl injection is labeled for the treatment and control of swine bacterial respiratory disease (swine bacterial pneumonia) associated with Actinobacillus (Haemophilus) pleuropneumoniae, Pasteurella multocida, Salmonella choleraesuis and Streptococcus suis.
In cattle, ceftiofur HCl is labeled for the treatment of the following bacterial diseases: Bovine respiratory disease (BRD, shipping fever, pneumonia) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni; Acute bovine interdigital necrobacillosis (foot rot, pododermatitis) associated with Fusobacterium necrophorum and Bacteroides melaninogenicus; and acute metritis (0 - 14 days post-partum) associated with bacterial organisms susceptible to ceftiofur.
The intramammary syringe for dry dairy cattle (Spectramast DC?) is labeled for the treatment of subclinical mastitis in dairy cattle at the time of dry off associated with Staphylococcus aureus, Streptococcus dysgalactiae, and Streptococcus uberis. The intramammary syringe for lactating dairy cattle (Spectramast LC?) is labeled for the treatment of clinical mastitis in lactating dairy cattle associated with coagulase-negative staphylococci, Streptococcus dysgalactiae, and Escherichia coli.